| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034713 |
| Receipt No. | R000039459 |
| Scientific Title | Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate : a randomised controlled study |
| Date of disclosure of the study information | 2018/10/31 |
| Last modified on | 2020/07/29 (Ver. 2) |
| Basic information | ||
| Public title | Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate : a randomised controlled study | |
| Acronym | Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate : a randomised controlled study | |
| Scientific Title | Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate : a randomised controlled study | |
| Scientific Title:Acronym | Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate : a randomised controlled study | |
| Region |
|
|
| Condition | ||
| Condition | benign prostatic hyperplasia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to determine the benefit of preoperative and postoperative pelvic floor muscle exercise for early recovery of continence after HoLEP |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | urinary continent rate (no pad usage) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients start preoperative pelvic floor muscle exercise preoperatively from 28 days before surgery and continue postoperatively. | |
| Interventions/Control_2 | Patients start preoperative pelvic floor muscle exercise postoperatively alone. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1)Estimated prostate volume is 30 ml or more
2)Patients who will undergo Holmium laser enucleation of the prostate at our hospital 3)Patients who can continue pelvic floor muscle exercise on their own |
|||
| Key exclusion criteria | 1)Patients who can not continue pelvic floor muscle exercise on their own
2)Patients who have severe incontinence before surgery due to severe cerebrovascular disorder or spinal cord injury |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tohoku Medical and Pharmaceutical UniversityHospital
|
||||||
| Division name | Department of Urology | ||||||
| Zip code | |||||||
| Address | 1-12-1 Fukumuro, Miyagino-ku, Sendai, Miyagi | ||||||
| TEL | 022-259-1221 | ||||||
| goanan@tohoku-mpu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tohoku Medical and Pharmaceutical UniversityHospital | ||||||
| Division name | Department of Urology | ||||||
| Zip code | |||||||
| Address | 1-12-1 Fukumuro, Miyagino-ku, Sendai, Miyagi | ||||||
| TEL | 022-259-1221 | ||||||
| Homepage URL | |||||||
| goanan@tohoku-mpu.ac.jp | |||||||
| Sponsor | |
| Institute | Tohoku Medical and Pharmaceutical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tohoku Medical and Pharmaceutical University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039459 |